The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC).
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer/Onyx; Celgene; Marval Biosciences; Onyx
Research Funding - Abbvie (Inst); ArQule (Inst); Bayer (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); Lilly (Inst); MethylGene (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Fatima A. Rangwala
Employment - GlaxoSmithKline; Novartis
Stock and Other Ownership Interests - GlaxoSmithKline; Novartis
 
Christel Rushing
No Relationships to Disclose
 
Donna Niedzwiecki
No Relationships to Disclose
 
Ivy Altomare
Consulting or Advisory Role - Amgen; Genentech; Incyte; Novartis
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Research Funding - Abbott Laboratories; Bristol-Myers Squibb; Genentech/Roche; Merrimack; Sanofi
 
Shiaowen David Hsu
No Relationships to Disclose
 
Yousuf Zafar
Employment - Novartis (I)
Stock and Other Ownership Interests - Novartis (I)
Consulting or Advisory Role - Genentech
 
Michael Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Etubics; Genentech/Roche; Ipsen; Lexicon; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Novartis
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Onyx (Inst); Precision Biologics (Inst)
 
David Z. Chang
No Relationships to Disclose
 
James Leroy Wells
Stock and Other Ownership Interests - Bristol-Myers Squibb; Lilly; Novo Nordisk
 
Kimberly L. Blackwell
Consulting or Advisory Role - AstraZeneca; Celgene; Genentech; Hospira; Novartis; Pfizer; Roche; Rockwell Medical; Sandoz
Research Funding - Celgene (Inst); Genentech (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Genentech; Hospira; Novartis; Pfizer; Roche; Rockwell Medical; Sandoz
 
P. Kelly Marcom
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Novartis (Inst); Veridex (Inst)
 
Anna Renee Webb
No Relationships to Disclose
 
Evan Dropkin
No Relationships to Disclose
 
Christy Arrowood
No Relationships to Disclose
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; Regeneron; Sanofi; TRACON Pharma
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); TRACON Pharma (Inst)